| Shareholder | |||||
|---|---|---|---|---|---|
HRTG GPE, LLC | 18.09% | 16.92M | -- | +16.92M | |
HRTG GPE, LLC | 18.09% | 16.92M | -- | +16.92M | |
Arch Venture Partners, L.P. | 16.09% | 15.04M | -- | +15.04M | |
Arch Venture Partners, L.P. | 16.09% | 15.04M | -- | +15.04M | |
Tassos Anastasios GianakakosCo-Founder, President, CEO & Chairman | 10.49% | 9.81M | -- | +9.81M | |
Tassos Anastasios GianakakosCo-Founder, President, CEO & Chairman | 10.49% | 9.81M | -- | +9.81M | |
FMR LLC | 9.86% | 9.22M | 9.83% | +9.22M | |
FMR LLC | 9.86% | 9.22M | 0.33% | +312.71K | |
Perceptive Advisors LLC | 8.77% | 8.20M | -- | +8.20M | |
Perceptive Advisors LLC | 8.77% | 8.20M | -- | +8.20M | |
T. Rowe Price Group, Inc. | 5.20% | 4.87M | -- | +4.87M | |
Jay EdelbergCo-founder & Chief Medical Officer | 4.91% | 4.60M | -- | +4.60M | |
Jay EdelbergCo-founder & Chief Medical Officer | 4.91% | 4.60M | -- | +4.60M | |
Capital Research and Management Company | 3.85% | 3.60M | -- | +3.60M | |
Capital Research and Management Company | 3.85% | 3.60M | -- | +3.60M | |
T. Rowe Price Group, Inc. | 2.41% | 2.26M | -- | +2.26M | |
Keith Johnson | 2.19% | 2.05M | -- | +2.05M | |
Kevin Kelly | 2.19% | 2.05M | -- | +2.05M | |
Kevin Kelly | 2.19% | 2.05M | -- | +2.05M | |
Keith Johnson | 2.19% | 2.05M | -- | +2.05M |
